LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 84 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $650,000 | -24.9% | 203,930 | +0.5% | 0.00% | – |
Q1 2022 | $866,000 | -34.3% | 202,816 | -28.6% | 0.00% | – |
Q4 2021 | $1,319,000 | +20.1% | 283,870 | +3.1% | 0.00% | – |
Q3 2021 | $1,098,000 | -6.5% | 275,416 | +0.4% | 0.00% | – |
Q2 2021 | $1,174,000 | -33.5% | 274,361 | -34.1% | 0.00% | – |
Q1 2021 | $1,766,000 | +13.4% | 416,587 | +3.7% | 0.00% | – |
Q4 2020 | $1,558,000 | -1.5% | 401,589 | +2.2% | 0.00% | – |
Q3 2020 | $1,582,000 | -6.4% | 392,763 | -1.0% | 0.00% | – |
Q2 2020 | $1,690,000 | +27.6% | 396,864 | +25.9% | 0.00% | – |
Q1 2020 | $1,324,000 | -51.9% | 315,278 | -55.0% | 0.00% | – |
Q4 2019 | $2,752,000 | -8.4% | 700,522 | +105.0% | 0.00% | -100.0% |
Q3 2019 | $3,006,000 | +2.7% | 341,680 | +8.0% | 0.00% | 0.0% |
Q2 2019 | $2,926,000 | +74.9% | 316,421 | +21.6% | 0.00% | – |
Q1 2019 | $1,673,000 | -61.0% | 260,273 | -42.8% | 0.00% | -100.0% |
Q4 2018 | $4,290,000 | -3.2% | 454,968 | +106.7% | 0.00% | 0.0% |
Q3 2018 | $4,430,000 | -25.8% | 220,114 | +7.6% | 0.00% | -50.0% |
Q2 2018 | $5,969,000 | +17.3% | 204,657 | +19.8% | 0.00% | 0.0% |
Q1 2018 | $5,087,000 | +1.4% | 170,842 | +9.5% | 0.00% | 0.0% |
Q4 2017 | $5,018,000 | -3.5% | 155,954 | +4.3% | 0.00% | 0.0% |
Q3 2017 | $5,202,000 | +24.5% | 149,579 | +6.6% | 0.00% | 0.0% |
Q2 2017 | $4,178,000 | +27.3% | 140,362 | +27.7% | 0.00% | +100.0% |
Q1 2017 | $3,281,000 | +77.7% | 109,933 | +4.4% | 0.00% | 0.0% |
Q4 2016 | $1,846,000 | -21.7% | 105,322 | +6.3% | 0.00% | 0.0% |
Q3 2016 | $2,357,000 | +53.2% | 99,111 | +3.0% | 0.00% | 0.0% |
Q2 2016 | $1,539,000 | -22.6% | 96,199 | +1.2% | 0.00% | 0.0% |
Q1 2016 | $1,988,000 | -15.8% | 95,082 | +8.7% | 0.00% | 0.0% |
Q4 2015 | $2,361,000 | -9.6% | 87,500 | -7.0% | 0.00% | -50.0% |
Q3 2015 | $2,613,000 | +58.7% | 94,069 | +39.9% | 0.00% | +100.0% |
Q2 2015 | $1,647,000 | +50.7% | 67,245 | +12.5% | 0.00% | 0.0% |
Q1 2015 | $1,093,000 | +4.3% | 59,795 | +5.1% | 0.00% | 0.0% |
Q4 2014 | $1,048,000 | +208.2% | 56,871 | +60.3% | 0.00% | – |
Q3 2014 | $340,000 | +85.8% | 35,481 | +77.1% | 0.00% | – |
Q2 2014 | $183,000 | +51.2% | 20,038 | +77.9% | 0.00% | – |
Q1 2014 | $121,000 | – | 11,264 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN | 240,000 | $1,116,000 | 99.38% |
TANG CAPITAL MANAGEMENT LLC | 9,607,934 | $44,677,000 | 8.98% |
HealthInvest Partners AB | 830,000 | $3,860,000 | 5.44% |
RTW INVESTMENTS, LP | 2,327,903 | $10,825,000 | 0.16% |
GLOBEFLEX CAPITAL L P | 185,598 | $864,000 | 0.09% |
WealthTrust Axiom LLC | 25,400 | $118,000 | 0.04% |
HOLLENCREST CAPITAL MANAGEMENT | 82,355 | $383,000 | 0.03% |
FIRST MIDWEST BANK TRUST DIVISION | 41,731 | $194,000 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 435,387 | $2,023,000 | 0.01% |
OCCUDO QUANTITATIVE STRATEGIES LP | 17,176 | $80,000 | 0.01% |